Greg Taylor

Gregory Taylor, MBA, currently serves as Vice President of Global Commercial Diagnostics at Owkin since July 2023. Previously, Gregory held several key positions at Roche from June 2015 to March 2023, including Head of International Business Leader & Market Development and Director of Enterprise Sales for North America, focusing on oncology, next-generation sequencing, and software solutions. Prior roles include Regional Account Manager at RainDance Technologies, Senior Molecular Account Executive at GenMark Diagnostics, and Director of Business Development at HTG Molecular Diagnostics. Gregory began a career in research as an R&D Scientist at Biotransplant Inc. and as a Research Associate at Boston Medical Center. Academically, Gregory holds an MBA from Isenberg School of Management, UMass Amherst, and a Bachelor of Science in Microbiology from the University of Massachusetts Amherst.